We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 06. | After market close (AMC) | $0.95 | — | — | $61.7M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $0.27 | — | — | $50.5M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $1.05 | — | — | $113.04M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $0.5 | — | — | $72.27M | Reported |
Consensus PT $21.5 · 1 analysts
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2024. 07. 16. | Janney Montgomery Scott | — | Initiate coverage | — → Buy | — | Janney Montgomery Scott: Buy |
| 2023. 11. 20. | Piper Sandler | — | Downgrade | Neutral → Underweight | — | Piper Sandler: Neutral → Underweight |
| 2023. 02. 13. | Piper Sandler | — | Downgrade | Overweight → Neutral | — | Piper Sandler: Overweight → Neutral |
| 2022. 05. 16. | Piper Sandler | — | Maintain | — → Overweight | — | Piper Sandler: Overweight |
| 2021. 11. 13. | Boenning & Scattergood | — | Downgrade | Outperform → Neutral | — | Boenning & Scattergood: Outperform → Neutral |
| 2020. 04. 07. | Piper Sandler | — | Maintain | — → Overweight | — | Piper Sandler: Overweight |